These results indicate that OG promotes anti-amyloidogenic APP α-processing and reduces cerebral amyloidosis in a mouse model of AD and that these anti-amyloidogenic effects of OG are elicited equally regardless of gender. The gene discussed is APP; the disease is Alzheimer disease.